Xanthoma of the Skin

Publisher Website
Google Scholar
Abstract
ALTHOUGH xanthomas have been long recognized as clinical entities, it is only in relatively recent years that there has been delineation of the correlated metabolic and biochemical faults associated with these lesions. Now that refined and accurate lipid studies are available to practitioners in more hospital and clinic laboratories, much more precise definition of a patient's systemic lipid abnormality, if any, can be achieved.1When diagnosis and etiology are clarified, more specific and effective therapy is possible. These laboratory methods also enable us better to follow the progress of a patient or to assess the efficacy of any method of therapy. Among both basic science and clinical workers, there has been increasing interest in states of lipid abnormality, or dyslipidoses. This reflects in part our increasing concern with the problems of an aging population, especially in reference to arteriosclerosis and its attendant degenerative and atheromatous complications. Although xanthomas occur

This publication has 0 references indexed in Scilit: